
Sanofi at ESC Congress 2026 | ASCVD & LDL-C Management
Discover how you can help change the trajectory of ASCVD.


Discover how you can help change the trajectory of ASCVD.




Despite major advances in our understanding of atherosclerosis, ASCVD remains the leading cause of death globally.1

A clinical consensus statement of Association for acute cardiovascular care (ACVC), in collaboration with European association of preventive cardiology (EAPC) and the European Society of Cardiology working group on cardiovascular Pharmacotherapy Krychtiuk KA, et al. Eur Heart J Acute Cardiovasc Care. 2022;11(12):939–949.

Key principles of lipid management (LDL-C in particular) in accordance with the 2019 ESC/EAS Guidelines for the management of dyslipidaemias, and the 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.



Felicita Andreotti, Italy; Christiaan J M Vrints, Belgium